Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection

Stuart Flanagan; Sophia De Saram; Rageshri Dhairyawan

doi:10.1136/bcr-2015-210213

Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection

BMJ Case Rep. 2015 Nov 24:2015:bcr2015210213. doi: 10.1136/bcr-2015-210213.

Authors

Stuart Flanagan¹, Sophia De Saram², Rageshri Dhairyawan³

Affiliations

¹ Department of Infection and Immunology, Royal London Hospital, London, UK.
² North Middlesex Hospital, London, UK.
³ Department of Sexual Health, Barking Community Hospital, London, UK.

Abstract

We report a case of a new diagnosis of HIV with an extremely high viral load presenting with HIV encephalopathy, in a 54-year-old woman who had been treated with 2 years of extended high-dose immunosuppressant therapy for a recalcitrant pruritic rash before diagnosis.

2015 BMJ Publishing Group Ltd.

Publication types

Case Reports

MeSH terms

AIDS Dementia Complex / diagnosis*
AIDS Dementia Complex / drug therapy
AIDS Dementia Complex / immunology
Anti-HIV Agents / administration & dosage*
Black People
CD4 Lymphocyte Count
Darunavir / administration & dosage
Delayed Diagnosis
Dermatitis, Atopic / drug therapy
Dermatitis, Atopic / immunology
Dermatitis, Atopic / virology*
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / administration & dosage
Female
HIV-1 / immunology*
HIV-1 / isolation & purification
Humans
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Middle Aged
Predictive Value of Tests
Prednisolone / administration & dosage*
Prednisolone / adverse effects
Raltegravir Potassium / administration & dosage
Ritonavir / administration & dosage
Treatment Outcome
Viral Load / drug effects
Viral Load / immunology*

Substances

Anti-HIV Agents
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Immunosuppressive Agents
Raltegravir Potassium
Prednisolone
Ritonavir
Darunavir